PAMU
TPTX

Pictet Asset Management (UK)’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Pictet Asset Management (UK)’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$84.7M Buy
1,085,793
+269,589
+33% +$19.9M 0.09% 253
2021
Q1 		$77.2M Buy
816,204
+50,938
+7% +$6.06M 0.09% 246
2020
Q4 		$93.2M Sell
765,266
-4,925
-0.6% -$540K 0.12% 208
2020
Q3 		$67.3M Sell
770,191
-372,990
-33% -$26M 0.11% 224
2020
Q2 		$73.8M Buy
1,143,181
+585,406
+105% +$33.8M 0.13% 203
2020
Q1 		$24.9M Sell
557,775
-25,153
-4% -$1.34M 0.05% 329
2019
Q4 		$36.3M Buy
582,928
+367,891
+171% +$17.5M 0.06% 332
2019
Q3 		$8.09M Buy
+215,037
New +$9.36M 0.02% 582

Other funds holding TPTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Pictet Asset Management (UK)'s TPTX Position: Q2 2021 in Review

Pictet Asset Management (UK) increased its Turning Point Therapeutics, Inc. Common Stock (TPTX) stake by 33% in Q2 2021, buying an estimated $19.9M and bringing the position to 1,085,793 shares worth $84.7M. The position accounts for 0.09% of the portfolio, ranked #253.

Pictet Asset Management (UK) first reported a position in TPTX in Q3 2019 and has held it in 8 quarters since. The position peaked at $93.2M in Q4 2020. 190 funds tracked by Wall St. Rank hold TPTX as of Q2 2021.

  • Pictet Asset Management (UK) held 1,085,793 shares of Turning Point Therapeutics, Inc. Common Stock worth $84.7M as of Q2 2021.
  • Pictet Asset Management (UK) bought 269,589 Turning Point Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $19.9M.
  • Turning Point Therapeutics, Inc. Common Stock made up 0.09% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #253 holding.
  • Pictet Asset Management (UK) first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and has held it in 8 quarters since.
  • Pictet Asset Management (UK)'s Turning Point Therapeutics, Inc. Common Stock position peaked at $93.2M in Q4 2020.
  • 190 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.